Food and Drug Administration Pleads With Congress for New Regulatory Powers After Eyedrops Recall Debacle
Recalls involving over-the-counter drops are drawing new attention to just how little American officials know about the conditions at some manufacturing plants on the other side of the world.
By MATTHEW PERRONE
||National
